Rift Valley fever
Information
- Disease name
- Rift Valley fever
- Disease ID
- DOID:1328
- Description
- "A viral infectious disease that results_in infection, has_material_basis_in Rift Valley fever virus, which is transmitted_by Aedes mosquitoes. The virus affects domestic animals (cattle, buffalo, sheep, goats, and camels) and humans. The infection has_symptom jaundice, has_symptom vomiting blood, has_symptom passing blood in the feces, has_symptom ecchymoses (caused by bleeding in the skin), has_symptom bleeding from the nose or gums, has_symptom menorrhagia and has_symptom bleeding from venepuncture sites." [url:http\://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/rvf/rvf_qa.htm, url:http\://www.who.int/mediacentre/factsheets/fs207/en/]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT04754776 | Completed | Early Phase 1 | Safety and Immunogenicity of a Candidate RVFV Vaccine (RVF001) | June 11, 2021 | April 6, 2022 |
NCT00287014 | Completed | Rift Valley Fever in Kenya | March 2006 | April 2006 | |
NCT00584194 | Completed | Phase 2 | Safety and Immunogenicity Study of Rift Valley Fever Vaccine | June 2004 | May 2010 |
NCT00869713 | Completed | Phase 2 | Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated | September 2009 | May 2021 |
NCT00415051 | Completed | Phase 2 | Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine | August 2006 | May 2009 |
NCT04672824 | Completed | Phase 1 | A Study to Assess the New Candidate Rift Valley Fever Virus Vaccine in Healthy Adults | May 31, 2022 | December 15, 2022 |
NCT05139524 | Recruiting | RVF and Other Emerging Infectious Diseases in East and Central Africa | October 8, 2021 | December 31, 2025 | |
NCT03609398 | Recruiting | Phase 2 | Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine | October 4, 2018 | December 2024 |
- Disase is a (Disease Ontology)
- DOID:934
- Cross Reference ID (Disease Ontology)
- ICD10CM:A92.4
- Cross Reference ID (Disease Ontology)
- MESH:D012295
- Cross Reference ID (Disease Ontology)
- NCI:C128419
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:7077006
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0035613
- OrphaNumber from OrphaNet (Orphanet)
- 319251
- ICD10 preferred id (Insert disease from ICD10)
- D0000443
- ICD10 class code (Insert disease from ICD10)
- A92.4
- MeSH unique ID (MeSH (Medical Subject Headings))
- D012295